Alaa Ahmed Youssef
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alaa Ahmed Youssef has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Asmaa A. Abo Elqasem
Immunology, Zoology and Entomology Department, Faculty of Science, Al-Azhar University (for Girls), Nasr City, Cairo, Egypt.
1 shared publication Basma Mohamed Abou-Elnour
Zoology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt
1 shared publicationHend M. El-Menyawy
Zoology Department, Faculty of Science, Al-Azhar University (Girls Branch), Cairo, Egypt
1 shared publicationIbrahim R. Aly
Zoology Department, Faculty of Science, Al-Azhar University (Girls Branch), Cairo, Egypt
1 shared publicationKarima M. Metwally
Zoology Department, Faculty of Science, Al-Azhar University (Girls Branch), Cairo, Egypt
1 shared publicationMoamena Bauomy Mahmoud
Medical Malacology Department, Theodor Bilharz Research Institute, Imbaba, Giza, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 July 2021
- Published by Egyptian Knowledge Bank in The Egyptian Journal of Hospital Medicine
- Vol. 84 (1) , 1818-1826
The Therapeutic role of Thymoquinone Bioactive Compound as Target Natural Product from Nigella sativa Loaded with Chitosan Nanoparticles on Schistosomiasis
Background: Schistosoma mansoni is a trematode helminth responsible for liver fibrosis or cirrhosis. Aim of the work: In the present work natural products Thymoquinone loaded with chitosan nanoparticle (TQ/ChNP)) (TQ/ChNP) were used to determine their therapeutic effect on S. mansoni infection. Materials and methods: A total of 40 healthy Swiss albino mice, 20-25 g in weight, procured from Theodor Bilharz Research Institute (TBRI) Imbaba, Egypt's Schistosome Biological Supply Center (SBSC). Results: The infected mice treated with TQ/ChNP showed a significant decrease in the total worm burden. Treatment with TQ/ChNP had a highly significant effect on mature worm burden, TQ/ChNP in prophylactic and therapeutic doses significantly increased the mean number of dead ova in comparison to control. TQ/ChNP had a high decrease effect on ova count in intestinal tissue and a moderate reduction on ova count in hepatic tissue. Prophylactic dose gave a high reduction effect on ova count in intestinal tissue. As regards the size of hepatic granuloma, TQ/ChNP had the highest significant reduction on mean granuloma diameter with noticeable improvement of hepatic pathology. TQ/ChNP treated group showed observable improvement of liver pathology with mild degeneration and slight-sized fibrocellular. Conclusion: Based on the outcome of this study, TQ/ChNP proved to have potential bioactivity against S. mansoni adult stages and its potentiality in improving hepatic pathology. Efficacy of TQ/ChNP to postpone progression in chronic liver diseases must be considered as preventive medicine in patients with hepatic disorders.
- 1 July 2021
- Published by Egyptian Knowledge Bank in The Egyptian Journal of Hospital Medicine
- Vol. 84 (1) , 1818-1826
Open AccessThe Therapeutic role of Thymoquinone Bioactive Compound as Target Natural Product from Nigella sativa Loaded with Chitosan Nanoparticles on Schistosomiasis
Background: Schistosoma mansoni is a trematode helminth responsible for liver fibrosis or cirrhosis. Aim of the work: In the present work natural products Thymoquinone loaded with chitosan nanoparticle (TQ/ChNP)) (TQ/ChNP) were used to determine their therapeutic effect on S. mansoni infection. Materials and methods: A total of 40 healthy Swiss albino mice, 20-25 g in weight, procured from Theodor Bilharz Research Institute (TBRI) Imbaba, Egypt's Schistosome Biological Supply Center (SBSC). Results: The infected mice treated with TQ/ChNP showed a significant decrease in the total worm burden. Treatment with TQ/ChNP had a highly significant effect on mature worm burden, TQ/ChNP in prophylactic and therapeutic doses significantly increased the mean number of dead ova in comparison to control. TQ/ChNP had a high decrease effect on ova count in intestinal tissue and a moderate reduction on ova count in hepatic tissue. Prophylactic dose gave a high reduction effect on ova count in intestinal tissue. As regards the size of hepatic granuloma, TQ/ChNP had the highest significant reduction on mean granuloma diameter with noticeable improvement of hepatic pathology. TQ/ChNP treated group showed observable improvement of liver pathology with mild degeneration and slight-sized fibrocellular. Conclusion: Based on the outcome of this study, TQ/ChNP proved to have potential bioactivity against S. mansoni adult stages and its potentiality in improving hepatic pathology. Efficacy of TQ/ChNP to postpone progression in chronic liver diseases must be considered as preventive medicine in patients with hepatic disorders.
- Open Access
- 1 December 2015
- Published by Elsevier in Asian Pacific Journal of Tropical Disease
- Vol. 5 (12) , 957-963
Alternations in parasitological, biochemical and molecular parameters of Biomphalaria alexandrina snails, intermediate host of Schistosoma mansoni, induced post exposure to the proposed snail biocontrol agent Phasmarhabditis hermaphrodita nematode
- 1 December 2015
- Published by Elsevier in Asian Pacific Journal of Tropical Disease
- Vol. 5 (12) , 957-963
Open AccessAlternations in parasitological, biochemical and molecular parameters of Biomphalaria alexandrina snails, intermediate host of Schistosoma mansoni, induced post exposure to the proposed snail biocontrol agent Phasmarhabditis hermaphrodita nematode